is retatrutide glp-1 or glp 3 for weight loss: Study shows 30% body weight loss Retatrutide vs Tirzepatide: Key Differences
Pay in 4 interest-free payments of $5.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
Retatrutide vs Tirzepatide: Key Differences Explained (2026) Peptide Sourcing Hub New GLP 3 drug significantly slashes both weight and blood sugar levels in Phase III trial Synedica Retatrutide Triple Agonist GLP 1 GIP Glucagon RetatrutideA Game Changer in Obesity Pharmacotherapy PMC Beyond GLP 1: Retatrutide's triple agonist mechanism (GLP 1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight losssurpassing semaglutide & tirzepatide. Evidence based protocols demand nutrition support alongside prescribing. Retatrutide, a GIP, GLP 1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double blind, placebo and active controlled, parallel group, phase 2 trial conducted in the USA The Lancet
Store: www.allread.ai · Domain: www.allread.ai




01053-X/asset/68ad1d8b-bb7e-4ca0-8f89-99384d885ca3/main.assets/gr2.jpg)





















